[Management of diabetic dialysis patients].
Kaizu
Kazo
K
Department of Nephrology and Blood Purification, Social Insurance Yokohama Central Hospital.
Abe
Masanori
M
Matsumoto
Koichi
K
D015415:Biomarkers / Q000097:blood; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D004044:Dietary Proteins / Q000008:administration & dosage; D018450:Disease Progression; D002149:Energy Intake; D019270:Fructosamine / Q000097:blood; D006442:Glycated Hemoglobin / Q000032:analysis; D017583:Hemodiafiltration; D006440:Hemofiltration; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000628:therapy; D006973:Hypertension / Q000150:complications / Q000628:therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011379:Prognosis; D006435:Renal Dialysis
D015415:Biomarkers; D004044:Dietary Proteins; D019270:Fructosamine; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents